ArticleProceedings of the National Academy of Sciences of the United States of America2021

Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22.

Qinglan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.